logo

For the Inventor, By the Inventor

Ledyard, CT, United States of America

Thomas C Crawford

This inventor holds 21 USPTO granted patents and 29 published patent applications, primarily in Antiinflammatory Compositions. Top assignee: Pfizer Corporation. Active years: 1978-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas C Crawford. Retrieved from https://idiyas.com/inventor/thomas-c-crawford

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 5

Forward Citations = 77(Granted Patents)


Location History:

  • New London County, CT (US) (1980)
  • New London, CT (US) (1981)
  • Gales Ferry, CT (US) (1982 - 1983)
  • County of New London, CT (US) (1983)
  • Norwich, CT (US) (1978 - 1984)
  • Groton, CT (US) (1989)
  • Glastonbury, CT (US) (1992)
  • Ledyard, CT (US) (1985 - 1997)

Company Filing History:

goldMedal21 out of 4,488 
 
Pfizer Corporation
 patents

Years Active: 1978-1997

Loading Chart...
Areas of Expertise:
Antiparasitic Intermediates
Prodrugs
Anti-Inflammatory
Oxindole
Penicillanic Acid
Ascorbic Acid
Halomethyl Esters
Esters
Methanediol
Ampicillin
Amoxicillin
21 patents (USPTO):Explore Patents
1. 5665708 - Process and antiparasitic intermediates for doramectin (1997-09-09),
2. 5118703 - Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides (1992-06-02),
3. 4994457 - Antiinflammatory compositions and methods (1991-02-19),
4. 4874757 - Antinflammatory compositions and methods (1989-10-17),
5. 4812455 - Antiinflammatory compositions and methods (1989-03-14),
6. 4766117 - Antiinflammatory compositions and methods (1988-08-23),
7. 4672061 - Antiinflammatory compositions and methods (1987-06-09),
8. 4665194 - Process for making 2-oxindole-1-carboxamides and intermediates therefor (1987-05-12),
9. 4652658 - Process for making 2-oxindole-1-carboxamides and intermediates therefor (1987-03-24),
10. 4579846 - Antiinflammatory compositions and methods (1986-04-01),
11. 4564614 - Antiinflammatory methods (1986-01-14),
12. 4559326 - Antiinflammatory compositions and methods (1985-12-17),
13. 4474698 - Process for preparing esters of penicillanic acid sulfone (1984-10-02),
14. 4421924 - Ascorbic acid intermediates and their preparation (1983-12-20),
15. 4419284 - Preparation of halomethyl esters (and related esters) of penicillanic (1983-12-06),

Title: Thomas C. Crawford: Innovator in Pharmaceutical Science

Introduction

Thomas C. Crawford, a prominent inventor based in Ledyard, Connecticut, is widely recognized for his significant contributions to pharmaceutical innovations. With a remarkable portfolio of 21 patents, he has played an instrumental role in advancing medicinal chemistry, particularly in the development of antiparasitic and anti-inflammatory medications.

Latest Patents

Some of Thomas's latest patents highlight his innovative approach to drug development. Among them are a patent for "Process and antiparasitic intermediates for doramectin" and "Prodrugs of anti-inflammatory 3-acyl-2-oxindole-1-carboxamides." These patents reflect his dedication to creating effective therapeutic agents that have the potential to improve patient outcomes.

Career Highlights

As a key member of Pfizer Corporation, Thomas has leveraged his expertise in pharmaceutical chemistry to drive research and development efforts. His work at Pfizer has not only contributed to the company's reputation as a leader in the industry but also facilitated the advancement of treatments that benefit patients worldwide.

Collaborations

Throughout his career, Thomas has collaborated with several notable colleagues, including David L. Larson and Joseph G. Lombardino. These partnerships have been instrumental in fostering a collaborative environment that encourages the sharing of ideas and acceleration of innovative solutions in drug design and development.

Conclusion

Thomas C. Crawford's contributions to pharmaceutical science exemplify the impact of dedicated inventors in the field of medicine. Through his innovative patents and professional collaborations, he continues to influence the development of vital therapeutic agents, solidifying his legacy as a leading figure in the realm of pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…